M. Djonovic

SARS-CoV-2 Subunit Virus-like Vaccine Demonstrates High Safety Profile and Protective Efficacy: Preclinical Study

R. Deev, A. Isaev, M. Stukova, 2022, bioRxiv.

Safety and Immunogenicity of Betuvax-CoV-2, an RBD-Fc-Based SARS-CoV-2 Recombinant Vaccine: Preliminary Results of the First-in-Human, Randomized, Double-Blind, Placebo-Controlled Phase I/II Clinical Trial

M. Stukova, D. Lioznov, R. Oseshnyuk, 2023, Vaccines.

TB skin test recombinant proteins as vaccine candidates

V. Lunin, T. Vinogradova, M. Dogonadze, 2022, Genes & Cells.